Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Jun
21
2017
PTO Litigation Report – June 21, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jun
21
2017
Lack of Distinctiveness as an Obstacle for EUTM Registration K&L Gates
Jun
20
2017
Seventh Circuit Court of Appeals' Decision Reins in Copyright Infringement Claims Relating to Home Designs von Briesen & Roper, s.c.
Jun
20
2017
Supreme Court Analyzes Key Provisions of Biologics Price Competition and Innovation Act of 2009 McDermott Will & Emery
Jun
20
2017
Computer-Based Publishing Patent Goes Offline after Alice Inquiry Proskauer Rose LLP
Jun
20
2017
A New Slant: Supreme Court Invalidates Bar to Registering “Disparaging” Trademarks Squire Patton Boggs (US) LLP
Jun
20
2017
Matal v. Tam: U.S. Supreme Court Holds Prohibition on Disparaging Trademarks Unconstitutional under First Amendment Mintz
Jun
20
2017
Supreme Court Slants in Favor of Rock Band in Landmark Trademark Case Womble Bond Dickinson (US) LLP
Jun
20
2017
SCOTUS Decision Reaffirms Free Speech in Disparaging Trademarks ArentFox Schiff LLP
Jun
20
2017
PTO Litigation Report – June 20, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jun
20
2017
Cleveland Clinic Decision Highlights Catch-22 Of Personalized Medicine Patents Foley & Lardner LLP
Jun
19
2017
Are Inter Partes Reviews “Quintessential” Agency Adjudications? Squire Patton Boggs (US) LLP
Jun
19
2017
Supreme Court Rules That Prohibition on Registration of Disparaging Trademarks is Unconstitutional Michael Best & Friedrich LLP
Jun
19
2017
Secrets to Protecting Trade Secrets Abroad Epstein Becker & Green, P.C.
Jun
19
2017
Just When You Thought Things Couldn’t Get Worse Via Application Of 101 Schwegman, Lundberg & Woessner, P.A.
Jun
16
2017
EP Opposition and US Inter Partes Review Decisions Go Hand In Hand Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jun
16
2017
A Comparison of US and EPO Post Grant Practices       Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jun
16
2017
Trademark Confusion Defused: How to Qualify Your Expert and Prove Reliable Trademark Confusion IMS Legal Strategies
Jun
16
2017
PTO Litigation Report – June 16, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jun
14
2017
Planned Motion to Dismiss Insufficient to Extend Rule 26(f) Deadlines Proskauer Rose LLP
Jun
14
2017
PTAB Invalidates Two Cisco Patents Found Valid and Infringed at the ITC Mintz
Jun
14
2017
SCOTUS Ruling Gives a Boost to Biosimilars; FDA Continues to Advance Products Through AdComs Mintz
Jun
14
2017
Exhausted by Exhaustion: Impression Products v. Lexmark Schwegman, Lundberg & Woessner, P.A.
Jun
14
2017
Supreme Court Delivers Big Patent-Dance-Limiting Win for Biosimilars ArentFox Schiff LLP
Jun
14
2017
PTO Litigation Report – June 14, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jun
14
2017
Supreme Court to Consider Constitutionality of PTAB Proceedings K&L Gates
Jun
14
2017
Humira Patents Invalidated in Inter Partes Reviews Morgan, Lewis & Bockius LLP
Jun
14
2017
Amgen v. Sandoz: The Supreme Court’s First Biosimilars Ruling Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins